摘要 |
FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention refers to medicine and concerns a hyperglycolised version of parental interferon type 1 wherein the hyperglycolised version of parental interferon type 1 has been modified to include at least three additional glycolised sites. ^ EFFECT: invention provides prolonged preservation in the subject in comparison with parental interferon type 1 that allows decreasing a dosage. ^ 93 cl, 2 ex, 32 dwg, 12 tbl |